Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence
NCT05748249
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
126
Enrollment
OTHER
Sponsor class
Conditions
Benign Paroxysmal Positional Vertigo
Vitamin D
Antioxidants
Interventions
DRUG:
Vertistop® D
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS